CoChat
Sign Up
Cited by 77

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

mTORC1 and mTORC2 differentially promote natural killer cell development

Yang, Chao, Tsaih, Shirng-Wern, Lemke, Angela, Flister, Michael J, Thakar, Monica S, Malarkannan, Subramaniam·2018·eLife
DOI 10.7554/elife.35619PMC PMC5976438
Open this paper in CoChat — free account

Abstract

Natural killer (NK) cells are innate lymphoid cells that are essential for innate and adaptive immunity. Mechanistic target of rapamycin (mTOR) is critical for NK cell development; however, the independent roles of mTORC1 or mTORC2 in regulating this process remain unknown. Ncr1iCre-mediated deletion of Rptor or Rictor in mice results in altered homeostatic NK cellularity and impaired development at distinct stages. The transition from the CD27+CD11b− to the CD27+CD11b+ stage is impaired in Rptor cKO mice, while, the terminal maturation from the CD27+CD11b+ to the CD27−CD11b+ stage is compromised in Rictor cKO mice. Mechanistically, Raptor-deficiency renders substantial alteration of the gene expression profile including transcription factors governing early NK cell development. Comparatively, loss of Rictor causes more restricted transcriptome changes. The reduced expression of T-bet correlates with the terminal maturation defects and results from impaired mTORC2-AktS473-FoxO1 signaling. Collectively, our results reveal the divergent roles of mTORC1 and mTORC2 in NK cell development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.35619

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. mTORC1 is essential for NK cell homeostasis and maturation. (A) Raptor expression in freshly-isolated NK cells from WT and Rptor cKO mice was evaluated via western blot. (B) CD3, NK1.1 staining of cells from various organs (left) and quantification of NK cells in each organ of WT and Rptor cKO mice (right). n = 4–8 pooled from two to four independent experiments. (C) Ki-67 staining was used to assess steady-state proliferation of NK cells gated on CD11b− population (left), and percentage of Ki-67+ cells (right). n = 3 pooled from three independent experiments. (D) Percentage of NK cells that are in the sinusoidal compartment of BM was demonstrated by CD45.2 staining (left) and quantified as both percentage and number of CD45.2+ NK cells per million lymphocytes (right). n = 3 pooled from three independent experiments. (E) CD27 and the CD11b expression on gated NK cells from BM and spleen of WT and Rptor cKO mice were assessed by flow cytometry (left), and percentages of each NK subsets were quantified (right). n = 7 pooled from three independent experiments. (F) The KLRG1 expression on gated NK cells from BM and spleen of WT and Rptor cKO mice (left) and percentage of KLRG1+ cells within NK populations from different organs (right). n = 4 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA (B, C, E, F) or unpaired Student t-test (D). *p<0.05; **p<0.01; ***p<0.001.
Figure 1. mTORC1 is essential for NK cell homeostasis and maturation. (A) Raptor expression in freshly-isolated NK cells from WT and Rptor cKO mice was evaluated via western blot. (B) CD3, NK1.1 staining of cells from various organs (left) and quantification of NK cells in each organ of WT and Rptor cKO mice (right). n = 4–8 pooled from two to four independent experiments. (C) Ki-67 staining was used to assess steady-state proliferation of NK cells gated on CD11b− population (left), and percentage of Ki-67+ cells (right). n = 3 pooled from three independent experiments. (D) Percentage of NK cells that are in the sinusoidal compartment of BM was demonstrated by CD45.2 staining (left) and quantified as both percentage and number of CD45.2+ NK cells per million lymphocytes (right). n = 3 pooled from three independent experiments. (E) CD27 and the CD11b expression on gated NK cells from BM and spleen of WT and Rptor cKO mice were assessed by flow cytometry (left), and percentages of each NK subsets were quantified (right). n = 7 pooled from three independent experiments. (F) The KLRG1 expression on gated NK cells from BM and spleen of WT and Rptor cKO mice (left) and percentage of KLRG1+ cells within NK populations from different organs (right). n = 4 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA (B, C, E, F) or unpaired Student t-test (D). *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 1—figure supplement 1. mTORC1 is required for NK cell maturation. (A) BM and spleen lymphocytes count in WT and Rptor cKO mice. n = 4 pooled from two independent experiments. (B) The viability of freshly-isolated NK cells from BM and spleen of WT and Rptor cKO mice was evaluated by Annexin V (Ann V) and Propidium iodide (PI) staining (left). Percentage of live cells (Ann V−PI−) in each population gated by CD27 and CD11b was quantified (right). n = 3 pooled from three independent experiments. (C) Number of iNKs (CD3−CD122+NK1.1+DX5−), mNKs (CD3−CD122+NK1.1+DX5+) in the spleen and NKPs (CD3−Flt3−CD27+2B4+CD127+CD122+ NK1.1−), iNKs, mNKs in the BM from Rptor cKO mice were quantified using flow cytometry. n = 3–5 pooled from two or three independent experiments. (D) Number of each NK cell population defined by CD27 and CD11b expression in BM and spleen was quantified as the number of cells per million lymphocytes. n = 7 pooled from four independent experiments. (E) CD27 and the CD11b expression on NK cells from liver, blood and lymph node (LN) were assessed by flow cytometry (left). Percentage of each NK subsets was quantified (right). n = 4 pooled from two to four independent experiments. (F) Expression of various maturation markers on NK cells was shown as fold change in MFI normalized to WT. n = 4 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 1—figure supplement 1. mTORC1 is required for NK cell maturation. (A) BM and spleen lymphocytes count in WT and Rptor cKO mice. n = 4 pooled from two independent experiments. (B) The viability of freshly-isolated NK cells from BM and spleen of WT and Rptor cKO mice was evaluated by Annexin V (Ann V) and Propidium iodide (PI) staining (left). Percentage of live cells (Ann V−PI−) in each population gated by CD27 and CD11b was quantified (right). n = 3 pooled from three independent experiments. (C) Number of iNKs (CD3−CD122+NK1.1+DX5−), mNKs (CD3−CD122+NK1.1+DX5+) in the spleen and NKPs (CD3−Flt3−CD27+2B4+CD127+CD122+ NK1.1−), iNKs, mNKs in the BM from Rptor cKO mice were quantified using flow cytometry. n = 3–5 pooled from two or three independent experiments. (D) Number of each NK cell population defined by CD27 and CD11b expression in BM and spleen was quantified as the number of cells per million lymphocytes. n = 7 pooled from four independent experiments. (E) CD27 and the CD11b expression on NK cells from liver, blood and lymph node (LN) were assessed by flow cytometry (left). Percentage of each NK subsets was quantified (right). n = 4 pooled from two to four independent experiments. (F) Expression of various maturation markers on NK cells was shown as fold change in MFI normalized to WT. n = 4 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 2. mTORC2 is pivotal for NK cell homeostasis and terminal maturation. (A) Rictor expression in IL-2-cultured NK cells isolated from WT and Rictor cKO mice was evaluated via western blot. A representative of three independent experiments. (B) CD3, NK1.1 staining of cells from various organs (left) and quantification of NK cells in each organ of WT and Rictor cKO mice (right). n = 4–7 pooled from two to four independent experiments. (C) Ki-67 staining was used to assess steady-state proliferation of NK cells gated on CD27+ population (left), and percentage of Ki-67+ cells (right). n = 3 pooled from three independent experiments. (D) Percentage of NK cells that are in the sinusoidal compartment of BM was demonstrated by CD45.2 staining (left) and quantified as both percentage and number of CD45.2+ NK cells per million lymphocytes (right). n = 3 pooled from three independent experiments. (E) CD27 and the CD11b expression on gated NK cells from BM and spleen of WT and Rictor cKO mice were assessed by flow cytometry (left), and percentages of each NK subsets were quantified (right). n = 6 pooled from four independent experiments. (F) The KLRG1 expression on gated NK cells from BM and spleen of WT and Rictor cKO mice (left) and percentage of KLRG1+ cells within NK populations from different organs (right). n = 3–4 pooled from two or three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA (B, C, E, F) or unpaired Student t-test (D). *p<0.05; **p<0.01; ***p<0.001.
Figure 2. mTORC2 is pivotal for NK cell homeostasis and terminal maturation. (A) Rictor expression in IL-2-cultured NK cells isolated from WT and Rictor cKO mice was evaluated via western blot. A representative of three independent experiments. (B) CD3, NK1.1 staining of cells from various organs (left) and quantification of NK cells in each organ of WT and Rictor cKO mice (right). n = 4–7 pooled from two to four independent experiments. (C) Ki-67 staining was used to assess steady-state proliferation of NK cells gated on CD27+ population (left), and percentage of Ki-67+ cells (right). n = 3 pooled from three independent experiments. (D) Percentage of NK cells that are in the sinusoidal compartment of BM was demonstrated by CD45.2 staining (left) and quantified as both percentage and number of CD45.2+ NK cells per million lymphocytes (right). n = 3 pooled from three independent experiments. (E) CD27 and the CD11b expression on gated NK cells from BM and spleen of WT and Rictor cKO mice were assessed by flow cytometry (left), and percentages of each NK subsets were quantified (right). n = 6 pooled from four independent experiments. (F) The KLRG1 expression on gated NK cells from BM and spleen of WT and Rictor cKO mice (left) and percentage of KLRG1+ cells within NK populations from different organs (right). n = 3–4 pooled from two or three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA (B, C, E, F) or unpaired Student t-test (D). *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 2—figure supplement 1. Terminal NK cell maturation was impaired in Rictor cKO mice. (A) BM and spleen lymphocytes count in WT and Rictor cKO mice. n = 4 pooled from two independent experiments. (B) The viability of freshly isolated NK cells from BM and spleen of WT and Rictor cKO mice was evaluated by Annexin V (Ann V) and Propidium iodide (PI) staining (left). Percentage of live cells (Ann V−PI−) in each population gated by CD27 and CD11b was quantified (right). n = 3 pooled from three independent experiments. (C) Number of iNKs (CD3−CD122+NK1.1+DX5−), mNKs (CD3−CD122+NK1.1+DX5+) in the spleen and NKPs (CD3−Flt3−CD27+2B4+CD127+CD122+NK1.1−), iNKs, mNKs in the BM from Rictor cKO mice were quantified using flow cytometry. n = 3–4 pooled from two or four independent experiments. (D) Number of each NK cell population defined by CD27 and CD11b expression in BM and spleen of WT and Rictor cKO mice was quantified as the number of cells per million lymphocytes. n = 6 pooled from four independent experiments. (E) CD27 and the CD11b expression on NK cells from liver, blood and lymph node (LN) of WT and Rictor cKO mice were assessed by flow cytometry (left). Percentage of each NK subsets was quantified (right). n = 3–4 pooled from two or three independent experiments. (F) Expression of various maturation markers on NK cells was shown as fold change in MFI normalized to WT. n = 4 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 2—figure supplement 1. Terminal NK cell maturation was impaired in Rictor cKO mice. (A) BM and spleen lymphocytes count in WT and Rictor cKO mice. n = 4 pooled from two independent experiments. (B) The viability of freshly isolated NK cells from BM and spleen of WT and Rictor cKO mice was evaluated by Annexin V (Ann V) and Propidium iodide (PI) staining (left). Percentage of live cells (Ann V−PI−) in each population gated by CD27 and CD11b was quantified (right). n = 3 pooled from three independent experiments. (C) Number of iNKs (CD3−CD122+NK1.1+DX5−), mNKs (CD3−CD122+NK1.1+DX5+) in the spleen and NKPs (CD3−Flt3−CD27+2B4+CD127+CD122+NK1.1−), iNKs, mNKs in the BM from Rictor cKO mice were quantified using flow cytometry. n = 3–4 pooled from two or four independent experiments. (D) Number of each NK cell population defined by CD27 and CD11b expression in BM and spleen of WT and Rictor cKO mice was quantified as the number of cells per million lymphocytes. n = 6 pooled from four independent experiments. (E) CD27 and the CD11b expression on NK cells from liver, blood and lymph node (LN) of WT and Rictor cKO mice were assessed by flow cytometry (left). Percentage of each NK subsets was quantified (right). n = 3–4 pooled from two or three independent experiments. (F) Expression of various maturation markers on NK cells was shown as fold change in MFI normalized to WT. n = 4 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 3. mTORC1 and mTORC2 differentially regulate the expression of Eomes and T-bet. (A–D) Histogram of Eomes (A, C) and T-bet (B, D) expression on each NK cell population gated by CD27 and CD11b of Rptor (A, B) or Rictor (C, D) cKO mice and their corresponding WT control. The histogram in grey presents the unstained control (top). Mean fluorescent intensity (MFI) is shown as fold change normalized to WT CD27 SP population (bottom). n = 4 pooled from three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 3. mTORC1 and mTORC2 differentially regulate the expression of Eomes and T-bet. (A–D) Histogram of Eomes (A, C) and T-bet (B, D) expression on each NK cell population gated by CD27 and CD11b of Rptor (A, B) or Rictor (C, D) cKO mice and their corresponding WT control. The histogram in grey presents the unstained control (top). Mean fluorescent intensity (MFI) is shown as fold change normalized to WT CD27 SP population (bottom). n = 4 pooled from three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 4. mTORC1 and mTORC2 differentially regulate the expression of CD122 and STAT5 activation. (A) Histogram of CD122 expression on each NK population gated by CD27 and CD11b of WT and Rptor cKO mice (left). MFI of CD122 was normalized to WT CD27 SP population (right). n = 3 pooled from three independent experiments. (B) Splenocytes from WT or Rptor cKO mice were stimulated with either medium or 100 ng/mL IL-15 for 1 hr. Phosphorylation of STAT5Y694 was detected by phosphor-flow and shown as the representative histogram of three independent experiments. (C, D) CD122 expression (C) and IL-15-mediated STAT5 activation (D) in WT or Rictor-deficient NK cells. Same experimental procedures as A and B. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 4. mTORC1 and mTORC2 differentially regulate the expression of CD122 and STAT5 activation. (A) Histogram of CD122 expression on each NK population gated by CD27 and CD11b of WT and Rptor cKO mice (left). MFI of CD122 was normalized to WT CD27 SP population (right). n = 3 pooled from three independent experiments. (B) Splenocytes from WT or Rptor cKO mice were stimulated with either medium or 100 ng/mL IL-15 for 1 hr. Phosphorylation of STAT5Y694 was detected by phosphor-flow and shown as the representative histogram of three independent experiments. (C, D) CD122 expression (C) and IL-15-mediated STAT5 activation (D) in WT or Rictor-deficient NK cells. Same experimental procedures as A and B. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 4—figure supplement 1. mTORC1 activity, Eomes and CD122 expression were concurrently reduced during the transition from DP to CD11b SP stage. (A) The MFI of CD132 in NK cells from BM and Spleen of Rptor cKO mice were normalized to WT control demonstrated as a bar graph. n = 4 pooled from two independent experiments. (B) Phosphorylation of rpS6S240/244 in different NK cell subsets defined by CD27 and CD11b from BM and spleen of WT mice was evaluated by flow cytometry (left). MFI of rpS6S240/244 was normalized to CD27 SP population and shown as percentages (right). n = 3 pooled from two independent experiments. (C) MFI of FSC of each NK subset was normalized to CD27 SP population from BM and spleen of WT mice and shown as percentages. n = 7 pooled from four independent experiments. (D) Eomes expression in three NK cell subsets is shown in fold change normalized to CD27 SP population. n = 8 pooled from four independent experiments. (E) CD122 expression in three NK cell subsets is shown in fold change normalized to CD27 SP population. n = 5 pooled from four independent experiments. (F) The MFI of CD132 in NK cells from BM and Spleen of Rictor cKO mice were normalized to WT control demonstrated as a bar graph. n = 3 pooled from three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 4—figure supplement 1. mTORC1 activity, Eomes and CD122 expression were concurrently reduced during the transition from DP to CD11b SP stage. (A) The MFI of CD132 in NK cells from BM and Spleen of Rptor cKO mice were normalized to WT control demonstrated as a bar graph. n = 4 pooled from two independent experiments. (B) Phosphorylation of rpS6S240/244 in different NK cell subsets defined by CD27 and CD11b from BM and spleen of WT mice was evaluated by flow cytometry (left). MFI of rpS6S240/244 was normalized to CD27 SP population and shown as percentages (right). n = 3 pooled from two independent experiments. (C) MFI of FSC of each NK subset was normalized to CD27 SP population from BM and spleen of WT mice and shown as percentages. n = 7 pooled from four independent experiments. (D) Eomes expression in three NK cell subsets is shown in fold change normalized to CD27 SP population. n = 8 pooled from four independent experiments. (E) CD122 expression in three NK cell subsets is shown in fold change normalized to CD27 SP population. n = 5 pooled from four independent experiments. (F) The MFI of CD132 in NK cells from BM and Spleen of Rictor cKO mice were normalized to WT control demonstrated as a bar graph. n = 3 pooled from three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 5. Transcriptome analyses of Raptor- or Rictor-deficient NK cells. RNAseq was conducted using CD11b− BM NK cells from littermate WT and Rptor cKO mice or CD27+ BM NK cells from littermate WT and Rictor cKO mice. (n = 3 per group). (A) Venn diagram demonstrating the number of genes that are differentially expressed (FDR < 0.05) in Raptor- or Rictor-deficient NK cells compared to their corresponding littermate WT control cells and the overlapping between those two genes list. (B, C) Volcano plot demonstrating the overall transcriptome alterations in Raptor- (B) or Rictor-deficient (C) NK cells compared to their corresponding littermate WT control cells. The orange/red dots represent genes that are significantly increased, while the aqua/dark blue dots represent genes that are significantly decreased in Raptor- and Rictor-deficient NK cells compared to the corresponding WT counterparts. We plotted all the genes with –Log10(p values) greater than 80 at the y-axis equal to 80. (D) A number of significantly up-regulated or down-regulated genes encoding proteins belonging to eIFs, eEFs, ribosome small (Rps) or large (Rpl) subunits family in Rptor cKO NK cells are quantified and presented in the bar graph. (E, F) Enrichment of PTEN signaling in Rictor cKO NK cells (E) and Eomes target genes in Rptor cKO NK cells (F) were demonstrated via the heatmap.
Figure 5. Transcriptome analyses of Raptor- or Rictor-deficient NK cells. RNAseq was conducted using CD11b− BM NK cells from littermate WT and Rptor cKO mice or CD27+ BM NK cells from littermate WT and Rictor cKO mice. (n = 3 per group). (A) Venn diagram demonstrating the number of genes that are differentially expressed (FDR < 0.05) in Raptor- or Rictor-deficient NK cells compared to their corresponding littermate WT control cells and the overlapping between those two genes list. (B, C) Volcano plot demonstrating the overall transcriptome alterations in Raptor- (B) or Rictor-deficient (C) NK cells compared to their corresponding littermate WT control cells. The orange/red dots represent genes that are significantly increased, while the aqua/dark blue dots represent genes that are significantly decreased in Raptor- and Rictor-deficient NK cells compared to the corresponding WT counterparts. We plotted all the genes with –Log10(p values) greater than 80 at the y-axis equal to 80. (D) A number of significantly up-regulated or down-regulated genes encoding proteins belonging to eIFs, eEFs, ribosome small (Rps) or large (Rpl) subunits family in Rptor cKO NK cells are quantified and presented in the bar graph. (E, F) Enrichment of PTEN signaling in Rictor cKO NK cells (E) and Eomes target genes in Rptor cKO NK cells (F) were demonstrated via the heatmap.CC BY · PubMed Central
Figure 5—figure supplement 1. Altered oxidative phosphorylation and integrin signaling in Raptor-deficient NK cells indicated by RNA sequencing. (A, B) IPA analyses revealed enrichment of oxidative phosphorylation (A) and integrin signaling (B) in Rptor cKO NK cells as demonstrated via the heatmap. (C) mRNA level of key transcription factors governing NK cell development in Raptor- (top) or Rictor- (bottom) deficient NK cells normalized to corresponding WT control.
Figure 5—figure supplement 1. Altered oxidative phosphorylation and integrin signaling in Raptor-deficient NK cells indicated by RNA sequencing. (A, B) IPA analyses revealed enrichment of oxidative phosphorylation (A) and integrin signaling (B) in Rptor cKO NK cells as demonstrated via the heatmap. (C) mRNA level of key transcription factors governing NK cell development in Raptor- (top) or Rictor- (bottom) deficient NK cells normalized to corresponding WT control.CC BY · PubMed Central
Figure 6. mTORC2 is required for T-bet expression through regulation of FoxO1 during NK cell development. (A) Enrichment of T-bet target genes in Rictor cKO NK cells as shown via the heatmap. (B) Histogram demonstrating phosphorylation of AktS473 (top) and FoxO1T24/FoxO3aT32 (bottom) in NK cells from BM of WT or Rictor cKO mice. The histogram in grey presents the isotype control. A representative of two or three independent experiments. (C) Enrichment of FoxO1 target genes in Rictor cKO NK cells as shown via the heatmap. (D) The mRNA level of Tbx21, Bcl2, Klf2, IL7r, and Ccr7 were evaluated by RT-qPCR with sorted fresh CD27+ NK cells from BM and spleen of WT or Rictor cKO mice. The data were shown as fold change normalized to WT. n = 3–5 pooled from three to five independent experiments. All bar graphs present the mean ± SD expect (D) which is shown as the mean ± SEM. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 6. mTORC2 is required for T-bet expression through regulation of FoxO1 during NK cell development. (A) Enrichment of T-bet target genes in Rictor cKO NK cells as shown via the heatmap. (B) Histogram demonstrating phosphorylation of AktS473 (top) and FoxO1T24/FoxO3aT32 (bottom) in NK cells from BM of WT or Rictor cKO mice. The histogram in grey presents the isotype control. A representative of two or three independent experiments. (C) Enrichment of FoxO1 target genes in Rictor cKO NK cells as shown via the heatmap. (D) The mRNA level of Tbx21, Bcl2, Klf2, IL7r, and Ccr7 were evaluated by RT-qPCR with sorted fresh CD27+ NK cells from BM and spleen of WT or Rictor cKO mice. The data were shown as fold change normalized to WT. n = 3–5 pooled from three to five independent experiments. All bar graphs present the mean ± SD expect (D) which is shown as the mean ± SEM. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 6—figure supplement 1. Cell surface expression of IL7Rα and Ccr7 are increased in Rictor cKO NK cells. (A, B) Cell surface expression of IL7Rα (A) and Ccr7 (B) in CD27+ NK cells from the spleen of WT and Rictor cKO mice were detected by flow cytometry as shown in the histogram on the left. Percentage positive cells were quantified on the right. The grey histogram was the unstained control. A representative of two independent experiments with three mice in each. All bar graphs present the mean ± SD. Statistical significance was calculated using unpaired student t test. *p<0.05; **p<0.01; ***p<0.001.
Figure 6—figure supplement 1. Cell surface expression of IL7Rα and Ccr7 are increased in Rictor cKO NK cells. (A, B) Cell surface expression of IL7Rα (A) and Ccr7 (B) in CD27+ NK cells from the spleen of WT and Rictor cKO mice were detected by flow cytometry as shown in the histogram on the left. Percentage positive cells were quantified on the right. The grey histogram was the unstained control. A representative of two independent experiments with three mice in each. All bar graphs present the mean ± SD. Statistical significance was calculated using unpaired student t test. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 7. Disruption of mTORC2 does not affect mTORC1 activation. (A, B) Splenocytes from WT, Rptor cKO (left) or Rictor cKO mice (right) were stimulated with either medium or 100 ng/mL IL-15 for 1 hr. Phosphorylation of rpS6S240/244 (A) and AktS473 (B) were detected by phosphor-flow and shown as the representative histogram of three independent experiments.
Figure 7. Disruption of mTORC2 does not affect mTORC1 activation. (A, B) Splenocytes from WT, Rptor cKO (left) or Rictor cKO mice (right) were stimulated with either medium or 100 ng/mL IL-15 for 1 hr. Phosphorylation of rpS6S240/244 (A) and AktS473 (B) were detected by phosphor-flow and shown as the representative histogram of three independent experiments.CC BY · PubMed Central
Figure 8. Impaired antitumor activity in Rptor or Rictor cKO mice. (A−D) 200,000 B16F10 tumor cells were intravenously injected into Rptor (A, B) or Rictor (C, D) cKO mice and their corresponding WT control mice. 14 days post-injection, the lungs were perfused with PBS and harvested for image acquisition (A, C) and HE staining (B, D; Scale bars represent 2.5 mm, and the right side are the 10X exploded view of select regions). The representative images were shown. n = 3–6 for each genotype from two independent experiments. (C, D) CTV-labeled splenocytes from WT C57BL/6 mice were mixed with CTV/CTR-double-labeled splenocytes from B2m−/− C57BL/6 mice at 1:1 ratio. Total 5 × 106 cells mixed cells were i.v. injected to Rptor (E) or Rictor (F) cKO mice and their corresponding WT control mice. 18 hr post-injection, the splenocytes from recipient mice were analyzed by flow cytometry. The percentages of WT and B2m−/− lymphocytes were analyzed as the representative histogram (left, gated on CTV+ lymphocytes). The percentage cytotoxicity was also calculated (right). n = 4–5, pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using unpaired Student t-test. *p<0.05; **p<0.01; ***p<0.001.
Figure 8. Impaired antitumor activity in Rptor or Rictor cKO mice. (A−D) 200,000 B16F10 tumor cells were intravenously injected into Rptor (A, B) or Rictor (C, D) cKO mice and their corresponding WT control mice. 14 days post-injection, the lungs were perfused with PBS and harvested for image acquisition (A, C) and HE staining (B, D; Scale bars represent 2.5 mm, and the right side are the 10X exploded view of select regions). The representative images were shown. n = 3–6 for each genotype from two independent experiments. (C, D) CTV-labeled splenocytes from WT C57BL/6 mice were mixed with CTV/CTR-double-labeled splenocytes from B2m−/− C57BL/6 mice at 1:1 ratio. Total 5 × 106 cells mixed cells were i.v. injected to Rptor (E) or Rictor (F) cKO mice and their corresponding WT control mice. 18 hr post-injection, the splenocytes from recipient mice were analyzed by flow cytometry. The percentages of WT and B2m−/− lymphocytes were analyzed as the representative histogram (left, gated on CTV+ lymphocytes). The percentage cytotoxicity was also calculated (right). n = 4–5, pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using unpaired Student t-test. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 9. mTORC1 is critical for the effector function of NK cells. In vivo Poly (I:C)-activated splenocytes were co-cultured with RMA/s target cells or stimulated with IL-12/IL-18 or PMA/Ionomycin for 6 hr. Medium and RMA target cells were used as the control groups. Degranulation (indicated by CD107a expression) and IFN-γ generation were assessed by flow cytometry. (A) Representative flow plots demonstrating the expression of CD107a and IFN-γ on gated NK cells from Rptor cKO and WT mice in different stimuli. (B) Percentage CD107a+, IFN-γ+NK cells from Rptor cKO and WT mice in different stimuli were quantified. The MFI of IFN-γ was normalized to WT in each condition. n ≥ 5, pooled from four independent experiments. (C, D) Expression of CD107a and IFN-γ in NK cells from Rictor cKO and WT mice (as shown in A and B). n = 3, pooled from three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.
Figure 9. mTORC1 is critical for the effector function of NK cells. In vivo Poly (I:C)-activated splenocytes were co-cultured with RMA/s target cells or stimulated with IL-12/IL-18 or PMA/Ionomycin for 6 hr. Medium and RMA target cells were used as the control groups. Degranulation (indicated by CD107a expression) and IFN-γ generation were assessed by flow cytometry. (A) Representative flow plots demonstrating the expression of CD107a and IFN-γ on gated NK cells from Rptor cKO and WT mice in different stimuli. (B) Percentage CD107a+, IFN-γ+NK cells from Rptor cKO and WT mice in different stimuli were quantified. The MFI of IFN-γ was normalized to WT in each condition. n ≥ 5, pooled from four independent experiments. (C, D) Expression of CD107a and IFN-γ in NK cells from Rictor cKO and WT mice (as shown in A and B). n = 3, pooled from three independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001.CC BY · PubMed Central
Figure 9—figure supplement 1. mTORC1 is essential for the IFN-γ generation downstream of NKG2D. (A) Standard 51Cr-release assay using IL-2-cultured WT NK cells against different target cells at various effector to target ratios in the presence of DMSO or Rapamycin (100 nM). n = 6 pooled from three independent experiments. (B) Standard 51Cr-release assay using IL-2-cultured WT and Rictor-deficient NK cells against different target cells at various effector to target ratios. n = 3 pooled from two independent experiments. (C) IL-2-cultured WT NK cells were stimulated with plate-bound NKG2D, PMA/Ionomycin or left along with medium in the presence of DMSO or Rapamycin (100 nM) for 6 hr. IFN-γ production was assessed via intracellular flow. n = 3 representative of three independent experiments. (D) IL-2-cultured WT or Rictor cKO NK cells were stimulated with plate-bound NKG2D, PMA/Ionomycin or left along with medium for 6 hr. IFN-γ production was assessed via intracellular flow. n = 3 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001. List of other files.
Figure 9—figure supplement 1. mTORC1 is essential for the IFN-γ generation downstream of NKG2D. (A) Standard 51Cr-release assay using IL-2-cultured WT NK cells against different target cells at various effector to target ratios in the presence of DMSO or Rapamycin (100 nM). n = 6 pooled from three independent experiments. (B) Standard 51Cr-release assay using IL-2-cultured WT and Rictor-deficient NK cells against different target cells at various effector to target ratios. n = 3 pooled from two independent experiments. (C) IL-2-cultured WT NK cells were stimulated with plate-bound NKG2D, PMA/Ionomycin or left along with medium in the presence of DMSO or Rapamycin (100 nM) for 6 hr. IFN-γ production was assessed via intracellular flow. n = 3 representative of three independent experiments. (D) IL-2-cultured WT or Rictor cKO NK cells were stimulated with plate-bound NKG2D, PMA/Ionomycin or left along with medium for 6 hr. IFN-γ production was assessed via intracellular flow. n = 3 pooled from two independent experiments. All bar graphs present the mean ± SD. Statistical significance was calculated using two-way ANOVA. *p<0.05; **p<0.01; ***p<0.001. List of other files.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 58

  1. Brunet, 1999, Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor, Cell, 96, 857, 10.1016/S0092-8674(00)80595-4 · DOI · Paper page
  2. Cahill, 2001, Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways, Journal of Biological Chemistry, 276, 13402, 10.1074/jbc.M010042200 · DOI
  3. Carotta, 2011, Identification of the earliest NK-cell precursor in the mouse BM, Blood, 117, 5449, 10.1182/blood-2010-11-318956 · DOI
  4. Chiossone, 2009, Maturation of mouse NK cells is a 4-stage developmental program, Blood, 113, 5488, 10.1182/blood-2008-10-187179 · DOI
  5. Curti, 2011, Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients, Blood, 118, 3273, 10.1182/blood-2011-01-329508 · DOI
  6. Daussy, 2014, T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow, The Journal of Experimental Medicine, 211, 563, 10.1084/jem.20131560 · DOI
  7. Delconte, 2016, The helix-loop-helix protein ID2 governs NK cell fate by tuning their sensitivity to interleukin-15, Immunity, 44, 103, 10.1016/j.immuni.2015.12.007 · DOI
  8. Deng, 2015, Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function, Immunity, 42, 457, 10.1016/j.immuni.2015.02.006 · DOI
  9. Di Santo, 2006, Natural killer cell developmental pathways: a question of balance, Annual Review of Immunology, 24, 257, 10.1146/annurev.immunol.24.021605.090700 · DOI
  10. DiSanto, 1995, Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain, PNAS, 92, 377, 10.1073/pnas.92.2.377 · DOI
  11. Eckelhart, 2011, A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development, Blood, 117, 1565, 10.1182/blood-2010-06-291633 · DOI
  12. Fathman, 2011, Identification of the earliest natural killer cell-committed progenitor in murine bone marrow, Blood, 118, 5439, 10.1182/blood-2011-04-348912 · DOI
  13. Finck, 2006, PGC-1 coactivators: inducible regulators of energy metabolism in health and disease, Journal of Clinical Investigation, 116, 615, 10.1172/JCI27794 · DOI
  14. Firth, 2013, Nfil3-independent lineage maintenance and antiviral response of natural killer cells, The Journal of Experimental Medicine, 210, 2981, 10.1084/jem.20130417 · DOI
  15. Gordon, 2012, The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation, Immunity, 36, 55, 10.1016/j.immuni.2011.11.016 · DOI
  16. Grundy, 2007, NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo, Cancer Immunology, Immunotherapy, 56, 1153, 10.1007/s00262-006-0264-1 · DOI
  17. Gu, 2000, New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway, Molecular and Cellular Biology, 20, 7109, 10.1128/MCB.20.19.7109-7120.2000 · DOI
  18. Guertin, 2006, Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1, Developmental Cell, 11, 859, 10.1016/j.devcel.2006.10.007 · DOI
  19. Hara, 2002, Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action, Cell, 110, 177, 10.1016/S0092-8674(02)00833-4 · DOI
  20. Hayakawa, 2006, CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity, The Journal of Immunology, 176, 1517, 10.4049/jimmunol.176.3.1517 · DOI
  21. Hesslein, 2011, Transcriptional control of natural killer cell development and function, Advances in Immunology, 109, 45, 10.1016/B978-0-12-387664-5.00002-9 · DOI
  22. Huntington, 2007, NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation, The Journal of Immunology, 178, 4764, 10.4049/jimmunol.178.8.4764 · DOI
  23. Intlekofer, 2005, Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin, Nature Immunology, 6, 1236, 10.1038/ni1268 · DOI
  24. Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive, Nature Cell Biology, 6, 1122, 10.1038/ncb1183 · DOI
  25. Kennedy, 2000, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, The Journal of Experimental Medicine, 191, 771, 10.1084/jem.191.5.771 · DOI
  26. Kerdiles, 2009, Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor, Nature Immunology, 10, 176, 10.1038/ni.1689 · DOI
  27. Kim, 2002, mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery, Cell, 110, 163, 10.1016/S0092-8674(02)00808-5 · DOI
  28. Kim, 2002, In vivo developmental stages in murine natural killer cell maturation, Nature Immunology, 3, 523, 10.1038/ni796 · DOI
  29. Kim, 2017, Suppressor of cytokine signaling 2 negatively regulates NK cell differentiation by inhibiting JAK2 activity, Scientific Reports, 7, 46153, 10.1038/srep46153 · DOI
  30. Leong, 2015, PTEN regulates natural killer cell trafficking in vivo, PNAS, 112, E700, 10.1073/pnas.1413886112 · DOI
  31. Liu, 2015, PtdIns(3,4,5)P3-Dependent activation of the mTORC2 kinase complex, Cancer Discovery, 5, 1194, 10.1158/2159-8290.CD-15-0460 · DOI
  32. Male, 2014, The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression, The Journal of Experimental Medicine, 211, 635, 10.1084/jem.20132398 · DOI
  33. Marçais, 2014, The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells, Nature Immunology, 15, 749, 10.1038/ni.2936 · DOI
  34. Mayol, 2011, Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking, Blood, 118, 4863, 10.1182/blood-2011-06-362574 · DOI
  35. Meyuhas, 2000, Synthesis of the translational apparatus is regulated at the translational level, European Journal of Biochemistry, 267, 6321, 10.1046/j.1432-1327.2000.01719.x · DOI
  36. Miller, 2005, Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Blood, 105, 3051, 10.1182/blood-2004-07-2974 · DOI
  37. Nandagopal, 2014, The critical role of IL-15-PI3K-mTOR pathway in natural killer cell effector functions, Frontiers in Immunology, 5, 187, 10.3389/fimmu.2014.00187 · DOI
  38. Narni-Mancinelli, 2011, Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor, PNAS, 108, 18324, 10.1073/pnas.1112064108 · DOI
  39. Orange, 2002, Human natural killer cell deficiencies and susceptibility to infection, Microbes and Infection, 4, 1545, 10.1016/S1286-4579(02)00038-2 · DOI
  40. Ouyang, 2012, Novel Foxo1-dependent transcriptional programs control T(reg) cell function, Nature, 491, 554, 10.1038/nature11581 · DOI
  41. Pollizzi, 2015, mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation, Journal of Clinical Investigation, 125, 2090, 10.1172/JCI77746 · DOI
  42. Regunathan, 2005, NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors, Blood, 105, 233, 10.1182/blood-2004-03-1075 · DOI
  43. Rosmaraki, 2001, Identification of committed NK cell progenitors in adult murine bone marrow, European Journal of Immunology, 31, 1900, 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M · DOI
  44. Rubnitz, 2010, NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia, Journal of Clinical Oncology, 28, 955, 10.1200/JCO.2009.24.4590 · DOI · Paper page
  45. Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Current Biology, 14, 1296, 10.1016/j.cub.2004.06.054 · DOI · Paper page
  46. Simonetta, 2016, T-bet and Eomesodermin in NK Cell Development, Maturation, and Function, Frontiers in Immunology, 7, 241, 10.3389/fimmu.2016.00241 · DOI
  47. Sun, 2011, NK cell development, homeostasis and function: parallels with CD8⁺ T cells, Nature Reviews Immunology, 11, 645, 10.1038/nri3044 · DOI
  48. Suzuki, 1997, Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain, The Journal of Experimental Medicine, 185, 499, 10.1084/jem.185.3.499 · DOI
  49. Townsend, 2004, T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells, Immunity, 20, 477, 10.1016/S1074-7613(04)00076-7 · DOI
  50. Wang, 2016, FoxO1-mediated autophagy is required for NK cell development and innate immunity, Nature Communications, 7, 11023, 10.1038/ncomms11023 · DOI
  51. Weichhart, 2015, Regulation of innate immune cell function by mTOR, Nature Reviews Immunology, 15, 599, 10.1038/nri3901 · DOI
  52. Whitman, 1988, Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate, Nature, 332, 644, 10.1038/332644a0 · DOI
  53. Williams, 2000, Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression, European Journal of Immunology, 30, 2074, 10.1002/1521-4141(200007)30:7<2074::AID-IMMU2074>3.0.CO;2-# · DOI
  54. Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
  55. Yang, 2015, PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness, The Journal of Experimental Medicine, 212, 253, 10.1084/jem.20141703 · DOI
  56. Yang, 2007, Expanding mTOR signaling, Cell Research, 17, 666, 10.1038/cr.2007.64 · DOI
  57. Zhang, 2016, Mammalian target of rapamycin complex 2 Controls CD8 T cell memory differentiation in a Foxo1-dependent manner, Cell Reports, 14, 1206, 10.1016/j.celrep.2015.12.095 · DOI · Paper page
  58. Zhu, 1994, Interleukin-2-induced tyrosine phosphorylation of shc proteins correlates with factor-dependent T cell proliferation, The Journal of Biological Chemistry, 269, 5518, 10.1016/S0021-9258(17)37491-4 · DOI

Cited by

Sorted by citations

Metadata

Authors
Yang, C., Tsaih, S.-W., Lemke, A., Flister, M. J., Thakar, M. S., & Malarkannan, S.
Affiliations
  • Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Blood Center of Wisconsin, Milwaukee, United States
  • Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, United States
ORCID
Malarkannan, Subramaniam
Venue
eLife
Publisher
eLife Sciences Publications, Ltd
Published
2018-05-29
Volume
7
ISSN
2050-084X
DOI
10.7554/elife.35619
PMC
PMC5976438
Cited by
77
References
6
Language
en
Licence
Funders
  • National Institute of Allergy and Infectious Diseases
  • National Cancer Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review